As of 2024-12-12, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is
-1.07 USD. This Atossa valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.26 USD, the upside of Atossa Therapeutics Inc is
-184.89%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.07 USD
Intrinsic Value
Atossa Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-1.07 - -1.07 |
-1.07 |
-184.89% |
| P/E |
(2.48) - (4.19) |
(3.99) |
-416.6% |
| DDM - Stable |
(1.20) - (2.71) |
(1.95) |
-255.1% |
| DDM - Multi |
(0.04) - (0.08) |
(0.06) |
-104.5% |
Atossa Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
158.51 |
| Beta |
2.03 |
| Outstanding shares (mil) |
125.80 |
| Enterprise Value (mil) |
83.74 |
| Market risk premium |
4.60% |
| Cost of Equity |
13.78% |
| Cost of Debt |
5.00% |
| WACC |
8.72% |